143 related articles for article (PubMed ID: 9350776)
1. Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States.
Korgenski EK; Daly JA
J Clin Microbiol; 1997 Nov; 35(11):2989-91. PubMed ID: 9350776
[TBL] [Abstract][Full Text] [Related]
2. A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents.
Hill BC; Baker CN; Tenover FC
J Clin Microbiol; 2000 Mar; 38(3):1151-5. PubMed ID: 10699011
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006-2017.
Lönnqvist E; Barkoff AM; Mertsola J; He Q
J Glob Antimicrob Resist; 2018 Sep; 14():12-16. PubMed ID: 29486357
[TBL] [Abstract][Full Text] [Related]
4. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.
Wilson KE; Cassiday PK; Popovic T; Sanden GN
J Clin Microbiol; 2002 Aug; 40(8):2942-4. PubMed ID: 12149356
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.
Fry NK; Duncan J; Vaghji L; George RC; Harrison TG
Eur J Clin Microbiol Infect Dis; 2010 Sep; 29(9):1183-5. PubMed ID: 20521155
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
Cent Eur J Public Health; 2017 Dec; 25(4):282-286. PubMed ID: 29346850
[TBL] [Abstract][Full Text] [Related]
7. Minimum inhibitory concentrations of erythromycin and other antibiotics for Czech strains of Bordetella pertussis.
Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):12-5. PubMed ID: 25872990
[TBL] [Abstract][Full Text] [Related]
8. Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Nov; 43(44):807-10. PubMed ID: 7968996
[TBL] [Abstract][Full Text] [Related]
9. Antipneumococcal activity of telithromycin by agar dilution, microdilution, E test, and disk diffusion methodologies.
Davies TA; Kelly LM; Jacobs MR; Appelbaum PC
J Clin Microbiol; 2000 Apr; 38(4):1444-8. PubMed ID: 10747123
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of pertussis in Fukuoka: incidence and MICs of antibiotics for Bordetella pertussis isolate].
Horikawa K; Okada K; Ishibashi T; Murakami K; Ohbuchi N; Ueda K
Kansenshogaku Zasshi; 1995 Aug; 69(8):878-83. PubMed ID: 7594779
[TBL] [Abstract][Full Text] [Related]
11. Analysis of antibiotic sensitivity and resistance genes of Bordetella pertussis in Chinese children.
Lin X; Zou J; Yao K; Li L; Zhong L
Medicine (Baltimore); 2021 Jan; 100(2):e24090. PubMed ID: 33466172
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Hoppe JE; Bryskier A
Antimicrob Agents Chemother; 1998 Apr; 42(4):965-6. PubMed ID: 9559823
[TBL] [Abstract][Full Text] [Related]
13. Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics.
Hoppe JE; Paulus T
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):391-3. PubMed ID: 9758277
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of erythromycin-resistant Bordetella pertussis in Xi'an, China.
Wang Z; Cui Z; Li Y; Hou T; Liu X; Xi Y; Liu Y; Li H; He Q
Clin Microbiol Infect; 2014 Nov; 20(11):O825-30. PubMed ID: 24816168
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.
Mehaffey PC; Putnam SD; Barrett MS; Jones RN
J Clin Microbiol; 1996 Feb; 34(2):479-81. PubMed ID: 8789046
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.
Gordon KA; Fusco J; Biedenbach DJ; Pfaller MA; Jones RN
Antimicrob Agents Chemother; 2001 Dec; 45(12):3599-600. PubMed ID: 11709347
[TBL] [Abstract][Full Text] [Related]
17. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient.
Yao SM; Liaw GJ; Chen YY; Yen MH; Chen YH; Mu JJ; Chiang CS
J Med Microbiol; 2008 Dec; 57(Pt 12):1577-1580. PubMed ID: 19018032
[TBL] [Abstract][Full Text] [Related]
19. Is Bordetella pertussis susceptibility to erythromycin changing? MIC trends among Australian isolates 1971-2006.
Sintchenko V; Brown M; Gilbert GL
J Antimicrob Chemother; 2007 Nov; 60(5):1178-9. PubMed ID: 17827145
[No Abstract] [Full Text] [Related]
20. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance.
Bartkus JM; Juni BA; Ehresmann K; Miller CA; Sanden GN; Cassiday PK; Saubolle M; Lee B; Long J; Harrison AR; Besser JM
J Clin Microbiol; 2003 Mar; 41(3):1167-72. PubMed ID: 12624047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
